SCHEMBL20376338

SCHEMBL20376338

Cc1ccc(-c2sc(C(F)(F)F)nc2C(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 2/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.40
▸ ALOX5 P09917 1/20 0.39
▸ HDAC4 P56524 2/20 0.39
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ HIPK4 Q8NE63 1/20 0.39
▸ PTGER1 P34995 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ ALPL P05186 1/20 0.38
▸ ALPI P09923 1/20 0.38
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14705606 0.87 PTGS2 (0.54) PTGS2PTGS1KDM4ERAB9AALDH1A1
SCHEMBL13398662 0.86 KDM4E (0.46) PTGS2PTGS1KDM4EGAAALDH1A1
SCHEMBL268643 0.80 KDM4E (0.49) KDM4ERAB9AGAAALDH1A1ALOX5
SCHEMBL2547639 0.78 KDM4E (0.47) KDM4ERAB9AGAAALDH1A1ALOX5
SCHEMBL923230 0.77 KDM4E (0.58) KDM4ERAB9AGAAALDH1A1ALOX5
SCHEMBL269217 0.77 HCRTR1 (0.46) KDM4EGAAALDH1A1MAPTPIN1
SCHEMBL20376593 0.75 KDM4E (0.44) KDM4ERAB9AGAAALDH1A1ALOX5
SCHEMBL27834590 0.75 KDM4E (0.44) KDM4ERAB9AGAAALDH1A1ALOX5
SCHEMBL27786030 0.75 KDM4E (0.44) KDM4ERAB9AGAAALDH1A1ALOX5
SCHEMBL2185640 0.74 HIPK4 (0.48) PTGS2PTGS1KDM4ERAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2739143-B1 PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5- MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS FLYNN GARY A (US) 2018-07-11 — — EP disclosed
Send feedback